Please login to the form below

Not currently logged in
From: Sales

GSK divests cancer drugs to bring Novartis deal to completion

Firms also collaborating on joint consumer health venture

From: Healthcare

Greater Manchester to control its share of the NHS budget

UK flagThe north-west English region accounts for 5% of the country's health spending

From: Healthcare

Sanofi’s Lantus follow-up nears European approval

Sanofi receptionCHMP backing for Toujeo follows hot on the heels of its US approval by the FDA

From: Research

Sovaldi-Daklinza combo cures hep C in co-infected HIV patients

Phase III trial of BMS and Gilead antivirals cured 97% of patients

darwins medicine

Does 'trust leadership' feature in your strategy?

Pharma companies wanting to be more patient-focused will need to develop their people skills

2015: A year of promise and connectivity

How could technology impact healthcare in this year and what will be the key trends to follow?

Sanofi joins WHO-backed diabetes mHealth programme

Becomes sole pharma partner for Be Healthy, Be Mobile's diabetes arm

mHealth mobile phone

Ex Sanofi boss joins Boston start-up

Chris Viehbacher joins other industry veterans as the newest board member of PureTech

Sanofi Chris Viehbacher

Mapping KOL relationships

Network maps can deliver a wealth of information

Cidara Therapeutics makes senior appointments

Paul Daruwala and James Balkovec join the biotech

Eisai adds online patient stories to Belviq marketing

Belviq Voices 'online community' will feature weight loss patient experiences

Eisai Belviq Voices lorcaserin obesity

Featured jobs

Subscribe to our email news alerts


Add my company
Gower Publishing Limited

Gower is recognised as one of the world's leading publishers of specialist business and management books and resources. Our publishing...

Latest intelligence

Growing influence of pharmacists in the sale of Rx and OTC medicines
Find out how the changes within pharmacy have affected their influence over the sales of RX and OTC medicines in this whitepaper....
Drivers of 2014′s Soaring Drug Approvals
The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...
Russian innovation at the crossroads
Despite improvements, investors face rising risks...